» Articles » PMID: 29371986

MicroRNA-424/E2F6 Feedback Loop Modulates Cell Invasion, Migration and EMT in Endometrial Carcinoma

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Jan 27
PMID 29371986
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Our previous study explored the roles of microRNA-424 (miR-424) in the development of endometrial carcinoma (EC) and analyzed the miR-424/E2F7 axis in EC cell growth. In this study, we investigated the status of miR-424 in human endometrial cancer tissues, which were collected from a cohort of Zunyi patients. We found that the expression level of miR-424 was associated with clinical tumor stage, cell differentiation, lymph node metastasis and cell migration ability. Cell function experiments demonstrated that miR-424 overexpression suppressed the invasion and migration abilities of endometrial carcinoma cells . Bioinformatic predictions and dual-luciferase reporter assays suggested E2F6 as a possible target of miR-424. RT-PCR and western blot assays demonstrated that miR-424 transfection reduced the expression level of E2F6, while inhibiting miR-424 with ASO-miR-424 (antisense oligonucleotides of miR-424) increased the expression level of E2F6. Cell function experiments indicated that E2F6 transfection rescued the EC cell phenotype induced by miR-424. In addition, we also found that E2F6 negatively regulated miR-424 expression in EC cells. In summary, our results demonstrated that the miR-424/E2F6 feedback loop modulates cell invasion, migration and EMT in EC and that the miR-424/E2Fs regulation network may serve as a new and potentially important therapeutic target in EC.

Citing Articles

Role of miR-424 in the carcinogenesis.

Ghafouri-Fard S, Askari A, Hussen B, Taheri M, Dilmaghani N Clin Transl Oncol. 2023; 26(1):16-38.

PMID: 37178445 PMC: 10761534. DOI: 10.1007/s12094-023-03209-2.


lncRNA XIST/miR‑129‑2‑3p axis targets CCP110 to regulate the proliferation, invasion and migration of endometrial cancer cells.

Chen S, Liang Y, Shen Y, Wang X Exp Ther Med. 2023; 25(4):159.

PMID: 36911384 PMC: 9996364. DOI: 10.3892/etm.2023.11858.


Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.

Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H Genes (Basel). 2023; 14(2).

PMID: 36833320 PMC: 9956157. DOI: 10.3390/genes14020393.


Emerging Role of E2F Family in Cancer Stem Cells.

Xie D, Pei Q, Li J, Wan X, Ye T Front Oncol. 2021; 11:723137.

PMID: 34476219 PMC: 8406691. DOI: 10.3389/fonc.2021.723137.


The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis-A Systematic Review.

Klicka K, Grzywa T, Klinke A, Mielniczuk A, Wlodarski P Cancers (Basel). 2021; 13(14).

PMID: 34298609 PMC: 8304659. DOI: 10.3390/cancers13143393.


References
1.
Janda M, Gebski V, Davies L, Forder P, Brand A, Hogg R . Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial. JAMA. 2017; 317(12):1224-1233. DOI: 10.1001/jama.2017.2068. View

2.
Zhang M, Gao C, Yang Y, Li G, Dong J, Ai Y . MiR-424 Promotes Non-Small Cell Lung Cancer Progression and Metastasis through Regulating the Tumor Suppressor Gene TNFAIP1. Cell Physiol Biochem. 2017; 42(1):211-221. DOI: 10.1159/000477314. View

3.
Thanapprapasr D, Thanapprapasr K . Molecular therapy as a future strategy in endometrial cancer. Asian Pac J Cancer Prev. 2013; 14(6):3419-23. DOI: 10.7314/apjcp.2013.14.6.3419. View

4.
Bell D . Novel genetic targets in endometrial cancer. Expert Opin Ther Targets. 2014; 18(7):725-30. PMC: 4128487. DOI: 10.1517/14728222.2014.909414. View

5.
Li Q, Qiu X, Li Q, Wang X, Li L, Xu M . MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7. Oncol Rep. 2015; 33(5):2354-60. DOI: 10.3892/or.2015.3812. View